Minimal invasive transforaminal lumbar interbody fusion for treating degenerative lumbar disc disease

Background data: minimal invasive transforaminal inerbody fusion is less invasive method in treating degenerative lumbar disc disease with reduced blood loss, hospital stay and all functional outcome Patients and methods: 15 patients with degenerative lumbar disc disease and treated with MIS TILF managed at our institute between and April 2022 -October 2024. . .The patients were evaluated clinically (VAS for LBP and LL pain), radiologically (GLL, SLL, DSH, foraminal height, SCC and bony fusion), and functionally (ODI and modified Prolo score) at follow up visits . Results: Clinically, patients reported an improvement of their back and leg pain with a significant difference between pre-operative and immediate post-operative VAS (P < 0.001). There was an improvement with a statistically significant difference between pre-operative, during and at the final follow-up concerning VAS for LBP and LL pain, ODI & modified Prolo scores (P < 0.001) .one case superficial infection and other case with transient neurapraxia Conclusion: MIS TILF is safe method in treatment DDD with overall improvement in functional and radiological outcome.